Overview

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

Status:
Completed

Trial end date:
2007-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and efficacy of the various combinations of valsartan, HCTZ, and amlodipine in patients with moderate to severe hypertension.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Amlodipine
Hydrochlorothiazide
Valsartan